4//SEC Filing
ZAMBROWICZ BRIAN P 4
Accession 0001127602-13-008831
CIK 0001062822other
Filed
Feb 28, 7:00 PM ET
Accepted
Mar 1, 5:22 PM ET
Size
12.2 KB
Accession
0001127602-13-008831
Insider Transaction Report
Form 4
ZAMBROWICZ BRIAN P
EVP, Chief Scientific Officer
Transactions
- Tax Payment
Common Stock
2013-02-28$1.98/sh−11,692$23,150→ 234,139 total - Exercise/Conversion
Restricted Stock Units (Phantom Stock)
2013-02-28−21,250→ 42,500 total→ Common Stock (21,250 underlying) - Exercise/Conversion
Common Stock
2013-02-28+21,250→ 224,331 total - Exercise/Conversion
Common Stock
2013-02-28+21,500→ 245,831 total - Exercise/Conversion
Restricted Stock Units (Phantom Stock)
2013-02-28−21,500→ 64,500 total→ Common Stock (21,500 underlying)
Footnotes (4)
- [F1]Each restricted stock unit represents a contingent right to receive one share of common stock.
- [F2]Withholding of a portion of issued shares by the Company in satisfaction of shareholder's tax withholding obligations with respect thereto.
- [F3]Restricted stock units vest with respect to 25% of the shares subject to the restricted stock units on February 28, 2012 and vest an additional 25% on February 28 of each of the three succeeding years thereafter.
- [F4]Restricted stock units vest with respect to 25% of the shares subject to the restricted stock units on February 28, 2013 and vest an additional 25% on February 28 of each of the three succeeding years thereafter.
Documents
Issuer
LEXICON PHARMACEUTICALS, INC./DE
CIK 0001062822
Entity typeother
Related Parties
1- filerCIK 0001226231
Filing Metadata
- Form type
- 4
- Filed
- Feb 28, 7:00 PM ET
- Accepted
- Mar 1, 5:22 PM ET
- Size
- 12.2 KB